share_log

Form 144 | Recursion Pharmaceuticals(RXRX.US)高管拟出售2.31万股股份，价值约17.53万美元

Form 144 | Recursion Pharmaceuticals(RXRX.US) Officer Proposes to Sell 175.35K in Common Stocks

moomoo News ·  Apr 17 16:21

SEC FILLINGS DISCLOSED/ Apr 17, $Recursion Pharmaceuticals (RXRX.US)$ Officer Secora Michael intends to sell 23,124 shares of its common stock on Apr 17, with a total market value of approximately $175.35K.

Secora Michael has reduced shareholding in $Recursion Pharmaceuticals (RXRX.US)$ by 127.5K shares since Jan 17, 2024, with a total value of approximately $1.49 million.

1713385305102711330.png

Source: Announcement

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment